STAT3 and cancer: This abnormal persistent STAT3 activation increases the cancer cell tolerance, prevents rejection of cancer by the immune system, reduces the effectiveness of immunotherapy and enhances the effectiveness of oncogenesis (10, 17, 44, 50, 51).